Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose

PURPOSE: The aim of this study was to ascertain whether the absolute bioavailability of oral imatinib (Glivec®) during steady state plasma pharmacokinetics in cancer patients could be determined through a concomitant intravenous administration of a single 100 μg microdose of deuterium labeled imatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Roosendaal, Jeroen, Groenland, Stefanie L., Rosing, Hilde, Lucas, Luc, Venekamp, Nikkie, Nuijen, Bastiaan, Huitema, Alwin D. R., Beijnen, Jos H., Steeghs, Neeltje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351863/
https://www.ncbi.nlm.nih.gov/pubmed/32430518
http://dx.doi.org/10.1007/s00228-020-02888-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351863/
https://www.ncbi.nlm.nih.gov/pubmed/32430518
http://dx.doi.org/10.1007/s00228-020-02888-y

Ejemplares similares